Literature DB >> 8244344

Gaucher disease (Norrbottnian type III): probable founders identified by genealogical and molecular studies.

N Dahl1, P O Hillborg, A Olofsson.   

Abstract

Gaucher disease type III (GD) is found at a high frequency in northern Sweden. The contemporary Swedish index families are found in two geographically distinct clusters with the highest world-wide frequency of type III GD. A single T-to-C transition in exon 10 has previously been identified in patients from one of the two isolates and we report there the same mutation in the second isolate. Mutational analysis was combined with a genealogical reconstruction of 19 contemporary index families. Both clusters were traced back to two corresponding pairs of ancestors over a 9-13 generation span. Molecular studies show that the two clusters are compatible with a single founder who arrived in northern Sweden in or before the 16th century.

Entities:  

Mesh:

Year:  1993        PMID: 8244344     DOI: 10.1007/bf00216461

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Blood level of cerebrosides in Gaucher's disease.

Authors:  P O HILLBORG; L SVENNERHOLM
Journal:  Acta Paediatr       Date:  1960-11       Impact factor: 2.299

2.  Simplified detection of Nci mutation in Gaucher disease.

Authors:  N Dahl; M Lagerström; A Erikson; U Pettersson
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

3.  The distribution of the gene for the juvenile type of Gaucher disease in Sweden.

Authors:  L Iselius; P O Hillborg; J Lindsten
Journal:  Acta Paediatr Scand       Date:  1989-07

Review 4.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

6.  Gaucher disease--Norrbottnian type. I. General clinical description.

Authors:  S Dreborg; A Erikson; B Hagberg
Journal:  Eur J Pediatr       Date:  1980-03       Impact factor: 3.183

7.  Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene.

Authors:  N Dahl; M Lagerström; A Erikson; U Pettersson
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

  7 in total
  6 in total

Review 1.  Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

2.  A germline or de novo mutation in two families with Gaucher disease: implications for recessive disorders.

Authors:  Hamid Saranjam; Sameer S Chopra; Harvey Levy; Barbara K Stubblefield; Emerson Maniwang; Ian J Cohen; Hagit Baris; Ellen Sidransky; Nahid Tayebi
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

3.  Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.

Authors:  Aimee Donald; Cecilia Kämpe Björkvall; Ashok Vellodi; Timothy M Cox; Derralyn Hughes; Simon A Jones; Robert Wynn; Maciej Machaczka
Journal:  Orphanet J Rare Dis       Date:  2022-06-18       Impact factor: 4.303

Review 4.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

5.  The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects.

Authors:  Yoo-Mi Kim; Jin-Ho Choi; Gu-Hwan Kim; Young Bae Sohn; Jung Min Ko; Beom Hee Lee; Chong Kun Cheon; Han Hyuk Lim; Sun-Hee Heo; Han-Wook Yoo
Journal:  Orphanet J Rare Dis       Date:  2020-11-11       Impact factor: 4.123

6.  In-depth phenotyping for clinical stratification of Gaucher disease.

Authors:  Simona D'Amore; Kathleen Page; Aimée Donald; Khadijeh Taiyari; Brian Tom; Patrick Deegan; Chong Y Tan; Kenneth Poole; Simon A Jones; Atul Mehta; Derralynn Hughes; Reena Sharma; Robin H Lachmann; Anupam Chakrapani; Tarekegn Geberhiwot; Saikat Santra; Siddarth Banka; Timothy M Cox
Journal:  Orphanet J Rare Dis       Date:  2021-10-14       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.